Atlas Trials

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

Clinical trial NCT07256964 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07256964
Sponsor
Henan Cancer Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
TNBC - Triple-Negative Breast Cancer
Start date
2025-11-26
Primary completion
2028-12-31
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.